Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a randomized clinical trial and cost-utility analysis
Introduction:Dementia is a major public health concern due to its increasing prevalence, substantial caregiver burden, and high financial costs. Currently, antidementia drugs provide only symptomatic effect. The subject of prescribing these drugs in advanced stages is a matter of substantial debate,...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142138 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142138 |